Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 1/14/2015
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 1||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Blood lead increased, Dizziness, Gait disturbance, Headache, Pain in extremity, Syncope, Foot deformity
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, days:
Write-up:This spontaneous report was received from a patient''s mother via "news" refers to a 11 year old female patient. Medical history was not reported. On 26-APR-2014 the patient was vaccinated with the first dose of GARDASIL (lot number, expiration date, dosage and route were not reported) and on 31-OCT-2013 the second dose GARDASIL was administered, injection, intramuscular (lot number, expiration date and dosage were not reported). Concomitant therapy was not reported. The consumer informed that in November 2013 the patient presented crooked feet, feet pain, leg pain, walking difficulties, headache, fainting, dizziness and fainting. Due to the difficulties walking, the patient was referred to the hospital. Blood tests were performed to identify heavy metals, with positive results for lead. Chelation treatment was started to eliminate the lead in the blood. The outcome of the event were unknown. The patient''s mother considered that crooked feet was determined to be disability. Additional information has been requested.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166